Results 161 to 170 of about 139,370 (300)

Polycythemia Vera and Essential Thrombocythemia: A Nationwide Population‐Based Study on Treatment Patterns, Vascular Complications and Survival

European Journal of Haematology, EarlyView.
ABSTRACT Background Polycythemia vera (PV) and essential thrombocythemia (ET) are associated with a well‐recognized increased risk of thrombotic events, bleeding, and all‐cause mortality, but the frequency of these outcomes during treatment has rarely been assessed in large cohorts.
Anneli Enblom Larsson, Henrik Renlund, Björn Andréasson, Henrik Holmberg, Maria Liljeholm, Anders Själander   +5 more
wiley   +1 more source

Spinal Subdural Hematoma After Dual Antiplatelet Therapy. [PDF]

JACC Case Rep
Prakash N, Balakrishnan VK, Ramesh SS, Krishnamurthy P, Sudhir G, Karthik K, Dwarampudi SR, Kovurireddy H, N S S A, Shanmugam S.   +9 more
europepmc   +1 more source

Real‐World Selection of Venetoclax‐Obinutuzumab Versus BTK Inhibitor Therapy for Treatment‐Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

European Journal of Haematology, EarlyView.
ABSTRACT Introduction Novel targeted agents have transformed the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), including continuous BTK inhibitor (BTKi) therapy and time‐limited regimens such as venetoclax‐obinutuzumab (Ven‐O) and ibrutinib‐venetoclax (I + V).
Rebecca Tidswell, Carolyn Owen, Mona Shafey, Sarah Perry, Nanette Cox‐Kennett, Russell Sterrett, Anthea Peters, Robert Puckrin   +7 more
wiley   +1 more source

Antiplatelet therapy trends in Chinese ischemic stroke patients 2019-2024. [PDF]

Sci Rep
Wu M, Jiang H, Sun A, Zhu B, Zhao Z.
europepmc   +1 more source

Acalabrutinib in Chronic Lymphocytic Leukemia: Pharmacology and Emerging Clinical Perspectives

European Journal of Haematology, EarlyView.
ABSTRACT Acalabrutinib, a second‐generation Bruton's tyrosine kinase inhibitor (BTKi), is characterized by enhanced specificity and selectivity for BTK with minimal off‐target effects, offering a significant evolution in the treatment of chronic lymphocytic leukemia (CLL). Its mechanism of action, a covalent binding to Cys481 within the BTK active site,
Gianluca Gaidano, Romano Danesi
wiley   +1 more source

CYP2C19 Genotype-Guided Antiplatelet Therapy in Precision Medicine for Stroke. [PDF]

JACC Asia
Zhang Q, Liu T.
europepmc   +1 more source

Advances in emerging therapies 2008 [PDF]

, 2009
Higgins, P., Lees, K.R.
core   +1 more source

Clinical and Genetic Characterization of 269 Patients With Suspected Inherited Platelet Disorders: The Padua Monocentric Experience

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Background Inherited platelet disorders (IPDs) are rare hematologic conditions encompassing a heterogeneous spectrum of quantitative and qualitative platelet defects, frequently associated with variable clinical phenotypes and comorbidities. Accurate diagnosis necessitates comprehensive genetic characterization, detailed clinical and bleeding ...
Silvia Ferrari, Daniela Regazzo, Antonella Bertomoro, Anna Cerbo, Alessandro Galbiati, Elisabetta Cosi, Paolo Simioni   +6 more
wiley   +1 more source

Impact of antiplatelet therapy on the hemostatic efficacy of platelet-targeted FVIII gene therapy in hemophilia A mice. [PDF]

Blood Adv
Yu H, Schroeder JA, Mattson JG, Gao C, Shi Q.   +4 more
europepmc   +1 more source

Prognostic Impact of New‐Onset Atrial Fibrillation After Cardiac Arrest: Observations From a Federated Research Network

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Data on adverse events in patients developing atrial fibrillation (AF) after cardiac arrest (CA) are limited. Methods Retrospective analysis using the TriNetX network. Adults (≥ 18 years) with CA (ICD‐10‐CM I46) from 2014 to 2024 were divided into two cohorts: those with new‐onset AF (I48) within 2 days after CA and those without ...
Enrico Tartaglia, Tommaso Bucci, Amir Askarinejad, Michele Rossi, Muath Alobaida, Steven Ho Man Lam, Mert Kaskal, Andrea Galeazzo Rigutini, Shir Lynn Lim, Giuseppe Boriani, Gregory Y. H. Lip   +10 more
wiley   +1 more source